Two GDP Non-Compliance Reports published in March
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Two new GDP Non-Compliance Reports have recently been published in the EudraGMDP database, both following the identification of serious violations of Good Distribution Practice (GDP) requirements.
The first report, dated 20 March 2025 (report number: NCCENTROM/2025/001, inspection date: 11 December 2024), was issued by the Competent Authority of Cyprus (Pharmaceutical Services, Ministry of Health). It states that the wholesale distributor had supplied medicinal products to unauthorized entities, which is a clear violation of GDP standards.
The second report, dated 26 March 2025 (report number: 482076-103624037, inspection date: 04 December 2024), was published by the Austrian Federal Office for Safety in Health Care. Here, the authority notes in general terms that the distributor does not comply with the EU GDP Guideline, without specifying further details.
In both cases, the respective Wholesale Distribution Authorisation (WDA) was withdrawn.
Source: EudraGMDP Database *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


